2m 2m 2m 2m 2m 2m 2m
ABCELLERA BIOLOG (ABCL)
NASDAQ
$5.75+$0.005 (+0.09%)
Price as of Jun 23, 2026 6:41 PM EDT- $1.8BMarket Cap
- 72.37%1-Year Change
- BiotechnologyIndustry
ABCELLERA BIOLOG (ABCL)
$5.75+$0.005 (+0.09%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 27.2M -5.64% | 28.8M -24.17% | 38.0M -92.17% | 485.4M +29.38% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 27.2M -5.64% | 28.8M -24.17% | 38.0M -92.17% | 485.4M +29.38% | |
Sales and Marketing Expense | N/A N/A | 12.8M -9.88% | 14.2M +25.82% | 11.3M +63.03% | |
Research and Development Expense | -186.8M +11.70% | -167.3M -4.78% | -175.7M +62.83% | -107.9M +73.82% | |
Depreciation and Amortization Expense | 18.4M +47.08% | 12.5M -1.73% | 12.8M +42.50% | 9.0M -11.02% | |
Total Operating Expenses | 292.2M -14.95% | 343.6M +24.84% | 275.2M +2.35% | 268.9M +57.45% | |
Operating Profit | -217.1M -31.03% | -314.8M +32.70% | -237.2M -209.56% | 216.5M +5.92% | |
Interest Income | 28.3M -26.37% | 38.5M -8.93% | 42.2M +162.75% | 16.1M +382.85% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 28.3M -26.37% | 38.5M -8.93% | 42.2M +162.75% | 16.1M +382.85% | |
Total Nonoperating Income and Expense | 39.5M -65.46% | 114.4M +81.03% | 63.2M +179.70% | 22.6M +53.28% | |
Income before Taxes | -177.6M -11.38% | -200.4M +15.15% | -174.0M -172.79% | 239.1M +9.10% | |
Income Taxes | -31.2M -16.93% | -37.5M +35.85% | -27.6M -134.29% | 80.6M +22.68% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -146.4M -10.10% | -162.9M +11.24% | -146.4M -192.35% | 158.5M +3.29% | |
Net Income from Continuing Operations Applicable to Common | -177.6M -11.38% | -200.4M +15.15% | -174.0M -172.79% | 239.1M +9.10% | |
Basic EPS and Net Income | -0.49 -10.91% | -0.55 +7.84% | -0.51 -191.07% | 0.56 0.00% | |
Diluted EPS and Net Income | -0.49 -10.91% | -0.55 +7.84% | -0.51 -202.00% | 0.50 +4.17% | |
Basic Weighted Average Shares | 298.7M +1.49% | 294.3M +1.78% | 289.2M +1.44% | 285.1M +3.37% | |
Diluted Weighted Average Shares | 298.7M +1.49% | 294.3M +1.78% | 289.2M -8.15% | 314.8M -1.09% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 128.5M -17.79% | 156.3M +17.26% | 133.3M -65.51% | 386.5M -18.82% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 128.5M -17.79% | 156.3M +17.26% | 133.3M -65.51% | 386.5M -18.82% | |
Total Current Assets | 728.2M -3.08% | 751.4M -13.83% | 872.0M -14.97% | 1.0B +10.29% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | 18.5M +88.02% | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | 217.3M +94.65% | |
Total Long-Term Assets | 628.7M +3.21% | 609.2M -1.12% | 616.1M +19.54% | 515.4M +32.58% | |
Total Assets | 1.4B -0.26% | 1.4B -8.57% | 1.5B -3.43% | 1.5B +16.86% | |
Income Taxes Payable | 9.1M -9.32% | 10.1M -67.16% | 30.6M -55.55% | 68.9M -5.74% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 64.3M -16.06% | 76.6M -35.63% | 119.0M +0.59% | 118.3M -1.95% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 325.7M +42.96% | 227.9M +5.12% | 216.8M +14.50% | 189.3M +9.96% | |
Total Liabilities | 390.0M +28.11% | 304.5M -9.32% | 335.8M +9.15% | 307.6M +5.05% | |
Retained Earnings | -29.5M -125.21% | 116.9M -58.21% | 279.8M -34.35% | 426.2M +59.22% | |
Total Stockholders Equity | 966.9M -8.44% | 1.1B -8.35% | 1.2B -6.56% | 1.2B +20.23% | |
Total Shares Outstanding | 300.6M +1.64% | 295.8M +1.70% | 290.8M +1.39% | 286.9M +1.27% | |
Cash Flow | |||||
Cash from Operating Activities | -131.3M +20.95% | -108.6M +147.41% | -43.9M -115.82% | 277.4M +13.40% | |
Capital Expenditures | 42.8M -45.44% | 78.4M +1.88% | 76.9M +8.90% | 70.7M +20.89% | |
Cash from Investing Activities | 87.8M -27.72% | 121.4M +154.91% | -221.1M -37.30% | -352.6M +6.13% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 14.1M +10.28% | 12.8M +23.30% | 10.4M +736.12% | -1.6M -58.11% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -797.94% -26.91% | -1,091.69% +75.00% | -623.82% -1,498.62% | 44.60% N/A | |
Return on Assets | -10.78% -5.76% | -11.43% +18.29% | -9.67% -187.18% | 11.09% N/A | |
Return on Equity | -14.47% -1.86% | -14.75% +20.17% | -12.27% -187.45% | 14.03% N/A | |
Revenue Growth | -5.64% -76.69% | -24.17% -73.77% | -92.17% -413.74% | 29.38% N/A | |
Current Ratio | 11.32 +15.47% | 9.81 +33.86% | 7.33 -15.46% | 8.67 N/A | |
Cash Ratio | 2.00 -2.06% | 2.04 +82.15% | 1.12 -65.71% | 3.27 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow